Low-Dose Tamoxifen Changes Breast Cancer Risk Biomarkers in High-Risk Women

https://www.medscape.com/viewarticle/low-dose-tamoxifen-changes-breast-cancer-risk-biomarkers-2026a10013sb?src= Low-dose tamoxifen raised sex hormone-binding globulin (SHBG) levels over 6 months in women at high risk for breast cancer, whereas intermittent caloric restriction showed smaller metabolic effects, a randomised phase 2 trial found.